Central Trust Company’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-121
Closed -$3.79K 1436
2025
Q2
$3.79K Hold
121
﹤0.01% 1247
2025
Q1
$4.62K Hold
121
﹤0.01% 1219
2024
Q4
$5.31K Buy
+121
New +$5.31K ﹤0.01% 1197
2022
Q3
Sell
-2
Closed 1333
2022
Q2
$0 Sell
2
-3,489
-100% -$225K ﹤0.01% 1386
2022
Q1
$239K Sell
3,491
-2,319
-40% -$165K 0.01% 537
2021
Q4
$460K Hold
5,810
0.01% 450
2021
Q3
$459K Sell
5,810
-23
-0.4% -$1.85K 0.02% 433
2021
Q2
$460K Sell
5,833
-35
-0.6% -$2.68K 0.02% 420
2021
Q1
$442K Sell
5,868
-12
-0.2% -$880 0.02% 404
2020
Q4
$387K Buy
5,880
+70
+1% +$4.09K 0.02% 401
2020
Q3
$314K Buy
+5,810
New +$319K 0.01% 394
2017
Q4
Sell
-23
Closed -$2K 1291
2017
Q3
$2K Buy
+23
New +$1.6K ﹤0.01% 1153

Other funds holding ENOV

Central Trust Company's ENOV Position: Q3 2025 in Review

Central Trust Company sold out of Enovis (ENOV) in Q3 2025, closing a stake of 121 shares — an estimated $3.79K sold.

Central Trust Company first reported a position in ENOV in Q3 2017 and held it in 12 quarters. The position peaked at $460K in Q4 2021. 278 funds tracked by Wall St. Rank hold ENOV as of Q3 2025.

  • Central Trust Company reported no remaining Enovis position as of Q3 2025 after selling out during the quarter.
  • Central Trust Company sold 121 Enovis shares in Q3 2025, an estimated $3.79K.
  • Central Trust Company first reported a position in Enovis in Q3 2017 and held it in 12 quarters.
  • Central Trust Company's Enovis position peaked at $460K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Enovis as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.